PharmPix CEO Dr. Martty Martínez Fraticelli Receives PBMI Excellence Award for Clinical Innovation
Dr. Martty Martínez Fraticelli, President and CEO of PharmPix, has been awarded the 2026 PBMI Excellence Award for Clinical Innovation by the Pharmacy Benefit Management Institute (PBMI). The award recognizes his leadership in integrating clinical intelligence into pharmacy benefit management to identify potential risks and inappropriate therapies before prescriptions are dispensed. Since co-founding PharmPix in 2009, Martínez Fraticelli has emphasized a clinically driven model that goes beyond administrative claims processing. Central to this vision is OneArk®, PharmPix's proprietary platform which combines adjudication with real-time clinical decision support and benefit configuration. This approach enables the identification of drug-related issues at the point of sale rather than through retrospective analysis, supporting safer medication use and cost management for health plans. The recognition aligns with broader industry changes under the Consolidated Appropriations Act 2026, which mandates greater transparency in pharmacy pricing.
Topics: clinical innovation healthcare technology pharmacy benefit management